Literature DB >> 12669051

Chromosomal translocation products engender new intracellular therapeutic technologies.

Terence H Rabbitts1, Martin R Stocks.   

Abstract

Mesh：

Year:  2003        PMID： 12669051     DOI： 10.1038/nm0403-383

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.

Authors:  Serena Racanicchi; Chiara Maccherani; Concetta Liberatore; Monia Billi; Vania Gelmetti; Maddalena Panigada; Giovanni Rizzo; Clara Nervi; Francesco Grignani
Journal:  EMBO J       Date:  2005-02-24       Impact factor: 11.598

2.  The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.

Authors:  Grace T Y Chung; Yoshihiro Yamada; Richard Pannell; Alan Forster; Terence H Rabbitts
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

3.  Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; P Andrew Futreal; Dianna B Roberts; Philip J Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S Weber; Scott M Lippman; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

4.  Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA.

Authors:  Roberto Plebani; Gavin R Oliver; Marco Trerotola; Emanuela Guerra; Pamela Cantanelli; Luana Apicella; Andrew Emerson; Alessandro Albiero; Paul D Harkin; Richard D Kennedy; Saverio Alberti
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

5.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

6.  Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins.

Authors:  Hedi Hegyi; László Buday; Peter Tompa
Journal:  PLoS Comput Biol       Date:  2009-10-30       Impact factor: 4.475

7.  Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions.

Authors:  Slobodan Vucetic; Hongbo Xie; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

8.  The EWS-Oct-4 fusion gene encodes a transforming gene.

Authors:  Jungwoon Lee; Ja Young Kim; In Young Kang; Hye Kyoung Kim; Yong-Mahn Han; Jungho Kim
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

9.  Decoding the fine-scale structure of a breast cancer genome and transcriptome.

Authors:  Stanislav Volik; Benjamin J Raphael; Guiqing Huang; Michael R Stratton; Graham Bignel; John Murnane; John H Brebner; Krystyna Bajsarowicz; Pamela L Paris; Quanzhou Tao; David Kowbel; Anna Lapuk; Dmitri A Shagin; Irina A Shagina; Joe W Gray; Jan-Fang Cheng; Pieter J de Jong; Pavel Pevzner; Colin Collins
Journal:  Genome Res       Date:  2006-02-03       Impact factor: 9.043

10.  EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.

Authors:  S Kim; B Lim; J Kim
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.